BDBM50336345 4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methyl)-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl)methyl)phenoxy)benzoic acid hydrochloride::APLAVIROC::CHEMBL1668019

SMILES CCCCN1C(=O)[C@H](NC(=O)C11CCN(Cc2ccc(Oc3ccc(cc3)C(O)=O)cc2)CC1)[C@H](O)C1CCCCC1

InChI Key InChIKey=GWNOTCOIYUNTQP-FQLXRVMXSA-N

Data  14 IC50  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50336345   

TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)
Affinity DataIC50:  5.80nMAssay Description:Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)
Affinity DataIC50:  5.80nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 4(Homo sapiens (Human))
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)
Affinity DataIC50:  3.00E+4nMAssay Description:Antagonist activity at CXCR4 assessed as inhibition of SDF1-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)
Affinity DataIC50:  46nMAssay Description:Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 5(Oryctolagus cuniculus)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)
Affinity DataIC50:  3.00E+4nMAssay Description:Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)
Affinity DataIC50:  5.60E+3nMAssay Description:Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressin...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)
Affinity DataIC50:  3.40E+4nMAssay Description:Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 5(Rattus norvegicus)
Ono Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50336345(4-(4-(((R)-1-butyl-3-((R)-cyclohexyl(hydroxy)methy...)
Affinity DataIC50:  3.00E+4nMAssay Description:Antagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilizationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed